The brimonidine-induced reduction in IOP in humans is associated with a decrease in aqueous flow and an increase in uveoscleral outflow. The decrease in IOP and aqueous flow in the contralateral control eye on day 8 compared with the baseline day suggests a mild contralateral effect.
|Original language||English (US)|
|Number of pages||4|
|Journal||Archives of Ophthalmology|
|State||Published - Dec 1995|
ASJC Scopus subject areas